Expression of transforming growth factor β pathway components in chronic graft-versus-host disease after allogeneic hematopoietic cell transplantation (2022)
- Authors:
- Autor USP: MACHADO NETO, JOÃO AGOSTINHO - ICB
- Unidade: ICB
- DOI: 10.1016/j.trim.2021.101514
- Subjects: FARMACOLOGIA; CÉLULAS-TRONCO; TRANSPLANTES; CÉLULAS SANGUÍNEAS; FATORES DE CRESCIMENTO; TECIDO CONJUNTIVO
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Título: Transplant Immunology
- ISSN: 1878-5492
- Volume/Número/Paginação/Ano: v. 70, art. 101514, p. 1-11, 2022
- Status:
- Nenhuma versão em acesso aberto identificada
-
ABNT
COLELLA, Marcos Paulo et al. Expression of transforming growth factor β pathway components in chronic graft-versus-host disease after allogeneic hematopoietic cell transplantation. Transplant Immunology, v. 70, p. 1-11, 2022Tradução . . Disponível em: https://doi.org/10.1016/j.trim.2021.101514. Acesso em: 01 abr. 2026. -
APA
Colella, M. P., Morini, B. C., Niemann, F. S., Lopes, M. R., Vigorito, A. C., Aranha, F. J. P., et al. (2022). Expression of transforming growth factor β pathway components in chronic graft-versus-host disease after allogeneic hematopoietic cell transplantation. Transplant Immunology, 70, 1-11. doi:10.1016/j.trim.2021.101514 -
NLM
Colella MP, Morini BC, Niemann FS, Lopes MR, Vigorito AC, Aranha FJP, Machado Neto JA, Saad SO, Favaro P. Expression of transforming growth factor β pathway components in chronic graft-versus-host disease after allogeneic hematopoietic cell transplantation [Internet]. Transplant Immunology. 2022 ; 70 1-11.[citado 2026 abr. 01 ] Available from: https://doi.org/10.1016/j.trim.2021.101514 -
Vancouver
Colella MP, Morini BC, Niemann FS, Lopes MR, Vigorito AC, Aranha FJP, Machado Neto JA, Saad SO, Favaro P. Expression of transforming growth factor β pathway components in chronic graft-versus-host disease after allogeneic hematopoietic cell transplantation [Internet]. Transplant Immunology. 2022 ; 70 1-11.[citado 2026 abr. 01 ] Available from: https://doi.org/10.1016/j.trim.2021.101514 - Silencing of ARHGAP21, a Rho GTPase activating protein (RhoGAP), reduces the growth of prostate cancer xenografts in NOD/SCID mice
- Prospecção de novos alvos farmacológicos relacionados a regulação do citoesqueleto em neoplasias hematológicas
- A decision support system to recommend appropriate therapy protocol for AML patients
- FLT3 mutation-related immune checkpoint molecule absent in melanoma 2 (AIM2) contributes to immune infiltration in pediatric and adult acute myeloid leukemia: evidence from bioinformatics analysis
- Emerging functions for ANKHD1 in cancer-related signaling pathways and cellular processes
- Targeting Ca2+ and mitochondrial homeostasis by antipsychotic thioridazine in Leukemia cells
- ZnO nanoparticles enhance the cytotoxic effects of a chalcone-sulfonamide hybrid by impairing the autophagic flux and upregulating HIF-1α expression
- Accelerating discoveries in medicine using distributed vector representations of words
- O uso de RNA mensageiro em tratamentos é um campo em expansão na ciência
- De novo AML exhibits greater microenvironment dysregulation compared to AML with myelodysplasia-related changes
Informações sobre a disponibilidade de versões do artigo em acesso aberto coletadas automaticamente via oaDOI API (Unpaywall).
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
